We are live on ! Find out more
RA

Ramius Advisors Portfolio holdings

AUM $95.2M
1-Year Est. Return 7.33%
This Fund
S&P 500
This Quarter Est. Return
+9.24%
1 Year Est. Return
+7.33%
3 Year Est. Return
+186.73%
5 Year Est. Return
10 Year Est. Return
AUM
$285M
AUM Growth
+$118M
Cap. Flow
+$112M
Cap. Flow %
39.13%
Top 10 Hldgs %
49.28%
Holding
433
New
200
Increased
94
Reduced
37
Closed
72

Sector Composition

Rank Sector Weight
1 Technology 15.44%
2 Financials 11.57%
3 Healthcare 7.58%
4 Communication Services 5.05%
5 Industrials 3.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBSAW
351
DELISTED
TB SA Acquisition Corp Warrant
TBSAW
$9K ﹤0.01%
17,593
EVOJW
352
DELISTED
Evo Acquisition Corp. Warrant
EVOJW
$7K ﹤0.01%
14,170
+3,070
+28% +$1.7K
LEGAW
353
DELISTED
Lead Edge Growth Opportunities, Ltd Warrant
LEGAW
$7K ﹤0.01%
10,000
GLTA.WS
354
DELISTED
Galata Acquisition Corp. Warrants, each whole warrant exercisable for one class A ordinary share at an exercise price of $11.50
GLTA.WS
$6K ﹤0.01%
+11,800
New +$6.02K
KLAQW
355
DELISTED
KL Acquisition Corp Warrant
KLAQW
$6K ﹤0.01%
11,021
GOGN.WS
356
DELISTED
GoGreen Investments Corporation Redeemable Warrants
GOGN.WS
$5K ﹤0.01%
+10,000
New +$4.7K
ATA.WS
357
DELISTED
Americas Technology Acquisition Corp.Redeemable Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50
ATA.WS
$5K ﹤0.01%
+10,873
New +$5.83K
MDH.WS
358
DELISTED
MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
MDH.WS
$5K ﹤0.01%
11,008
CEROW
359
DELISTED
CERo Therapeutics Warrants
CEROW
$4K ﹤0.01%
+10,000
New +$4.61K
ALACW
360
DELISTED
Alberton Acquisition Corp Warrant
ALACW
$4K ﹤0.01%
+21,502
New +$7.14K
CHNG
361
PUT
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$1K ﹤0.01%
12,500
-1,100
-8% -$23.1K
AMD icon
362
CALL
Advanced Micro Devices
AMD
$851B
-32,100
Closed -$24K
COCHW icon
363
Envoy Medical Warrant
COCHW
$536K
-19,176
Closed -$12K
DAVE icon
364
Dave Inc
DAVE
$5.12B
-2,087
Closed -$662K
EVH icon
365
Evolent Health
EVH
$475M
-20,000
Closed -$620K
FIVN icon
366
FIVE9
FIVN
$1.77B
-28,795
Closed -$6.25M
MDAIW icon
367
Spectral AI Warrants
MDAIW
$5.79M
-80,610
Closed -$44K
MX icon
368
Magnachip Semiconductor
MX
$128M
-118,636
Closed -$2.11M
RUMBW
369
RUM Group Inc Warrant
RUMBW
$12.1M
-26,259
Closed -$21K
SOND
370
DELISTED
Sonder
SOND
-6,351
Closed -$1.25M
SPY icon
371
State Street SPDR S&P 500 ETF Trust
SPY
$778B
-6,749
Closed -$2.9M
ZM icon
372
CALL
Zoom
ZM
$25.8B
-75,000
Closed -$122K
ZM icon
373
Zoom
ZM
$25.8B
-23,548
Closed -$6.16M
MSPRZ
374
DELISTED
MSP Recovery Inc Warrant
MSPRZ
-143,362
Closed -$123K
MVLA
375
DELISTED
Movella Holdings Inc. Common Stock
MVLA
-24,900
Closed -$246K

Similar funds

Ramius Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Ramius Advisors held 433 positions worth $285M, up 70% from $168M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Ramius Advisors deployed $112M of net new capital in Q4 2021, opening 200 new positions and adding to 94 existing holdings. Its largest new stake was Xilinx Inc: 110,898 shares worth $23.5M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Spartan Acquisition Corp. III, an estimated $557K trimmed.

  • Ramius Advisors's largest Q4 2021 buy was Xilinx Inc: 110,898 shares worth $23.5M.
  • Ramius Advisors added most to Nuance Communications, Inc. in Q4 2021, an estimated $35.5M increase.
  • Ramius Advisors's biggest Q4 2021 reduction was Spartan Acquisition Corp. III, cutting an estimated $557K.
  • Ramius Advisors fully exited Change Healthcare Inc. Common Stock in Q4 2021, selling an estimated $15.6M.
  • Ramius Advisors's ten largest holdings make up 49% of its $285M portfolio in Q4 2021.
  • Ramius Advisors opened 200 new positions and closed 72 in Q4 2021.
  • Ramius Advisors's portfolio value rose 70% quarter-over-quarter to $285M.

Based on Ramius Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.